![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Krka, D.d., Novo Mesto Novo Mesto Si, based in Slovenia, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Valsartan, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2011-148 - Rev 04
This Chemical Type CEP, issued on January 27, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2423 associated with this CEP further emphasizes